Kymera Therapeutics Inc Stock Performance
as on October 18, 2025 at 1:29 am IST
Day's Low
Day's High
$57.32$61.61
4.16%
Downside
3.01%
Upside
52 Week's Low
52 Week's High
$19.45$63.9667.49%
Downside
6.94%
Upside
Kymera Therapeutics Inc share price movements today
- Previous Close
- $60.46
- Open
- $59.97
- Volume
- 714.8K
- Day's Low - High
- $57.32 - $61.61
- 52 Week Low - High
- $19.45 - $63.96
Kymera Therapeutics Inc Historical Returns
- 1 Month Return
- + 16.95 %
- 3 Month Return
- + 29.56 %
- 1 Year Return
- + 28.92 %
- 3 Year Return
- + 127.66 %
- 5 Year Return
- + 55.89 %
Kymera Therapeutics Inc Stock Fundamentals & Key Indicators
Check Kymera Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$4.3B
EPS (TTM)
-3.4189
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-18.88
Industry PE ratio
8.355964912280701
PEG Ratio
0EBITDA
-305.1M
Revenue (TTM)
44.7M
Profit Margin
0.00%
Return On Equity TTM
89490600.00%
Kymera Therapeutics Inc Stock Valuation
Track how Kymera Therapeutics Inc P/E has moved over time to understand its valuation trends.
Kymera Therapeutics Inc in the last 5 years
Lowest (-43.30x)
March 31, 2021
Today (-18.88x)
October 18, 2025
Industry (8.36x)
October 18, 2025
Highest (-7.00x)
September 30, 2023
Today’s Price to Earnings Ratio: -18.88x
Kymera Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Kymera Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $4.3B | 55.89% | -18.88 | 0.00% | |
| BUY | $63.1B | 231.27% | -505.15 | -12.96% | |
| NA | $36.7B | NA | NA | -3.89% | |
| BUY | $104.8B | 91.13% | 29.04 | 31.86% | |
| BUY | $60.3B | -3.62% | 14.35 | 31.37% |
Stock Returns calculator for Kymera Therapeutics Inc Stock including INR - Dollar returns
The Kymera Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Kymera Therapeutics Inc investment value today
Current value as on today
₹1,33,668
Returns
₹33,668
(+33.67%)
Returns from Kymera Therapeutics Inc Stock
₹28,873 (+28.87%)
Dollar Returns*
₹4,794 (+4.79%)
Analyst Recommendation on Kymera Therapeutics Inc Stock
Based on 23 analysts
69.57%
Buy
30.43%
Hold
0.00%
Sell
Based on 23 analysts, 69.57% of analysts recommend a 'BUY' rating for Kymera Therapeutics Inc. Average target price of $64.6
Kymera Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Kymera Therapeutics Inc.
What analysts predicted
7.41%UPSIDE
Target Price
$64.6
Current Price
$59.81
Analyzed by
23 Analysts
Target
$64.60
Kymera Therapeutics Inc target price $64.6, a slight upside of 7.41% compared to current price of $59.81. According to 23 analysts rating.
Kymera Therapeutics Inc Stock’s Investor Sentiment and Interest
Search interest for Kymera Therapeutics Inc Stock has increased by 10% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:10% versus previous 30 day period
Kymera Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Kymera Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Kymera Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Kymera Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Insights on Kymera Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 month, KYMR stock has moved up by 21.8%
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.8% return, outperforming this stock by 33.9%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 150.9% return, outperforming this stock by 1.2%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, -65.58M → -76.61M (in $), with an average decrease of 16.8% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 22.1M → 11.47M (in $), with an average decrease of 48.1% per quarter
About Kymera Therapeutics Inc
| Organisation | Kymera Therapeutics Inc |
| Headquarters | 500 North Beacon Street, Watertown, MA, United States, 02472 |
| Industry | Health Technology |
| CEO | Dr. Nello Mainolfi M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Kymera Therapeutics Inc
Name | Title |
|---|---|
Dr. Jared A. Gollob M.D. | Chief Medical Officer |
Ms. Justine E. Koenigsberg | Vice President of Investor Relations |
Mr. Brian R. Adams J.D. | Chief Legal Officer & Corporate Secretary |
Ms. Karen Weisbach | Head of People & Culture |
Dr. Juliet Williams B.A Ph.D. | Head of Research |
Dr. Bruce L. Booth DPHIL, Ph.D. | Co-Founder & Independent Chairman |
Dr. Nello Mainolfi M.D., Ph.D. | Co-Founder, President, CEO & Director |
Mr. Bruce N. Jacobs CFA | Chief Financial Officer |
Dr. Jeremy G. Chadwick Ph.D. | Chief Operating Officer |
Mr. Noah Goodman M.B.A. | Chief Business Officer |
FAQs
What is Kymera Therapeutics Inc share price today?
Kymera Therapeutics Inc share price today is $59.81 as on at the close of the market. Kymera Therapeutics Inc share today touched a day high of $61.61 and a low of $57.32.
What is the 52 week high and 52 week low for Kymera Therapeutics Inc share?
Kymera Therapeutics Inc share touched a 52 week high of $63.96 on and a 52 week low of $19.45 on . Kymera Therapeutics Inc stock price today i.e. is closed at $59.81,which is 6.49% down from its 52 week high and 207.59% up from its 52 week low.
What is Kymera Therapeutics Inc's market capitalisation today?
Kymera Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Kymera Therapeutics Inc Stock (KYMR) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Kymera Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kymera Therapeutics Inc Shares that will get you 0.0251 shares as per Kymera Therapeutics Inc share price of $59.81 per share as on October 18, 2025 at 1:29 am IST.
What is the minimum amount required to buy Kymera Therapeutics Inc Stock (KYMR) from India?
Indian investors can start investing in Kymera Therapeutics Inc (KYMR) shares with as little as ₹87.954 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Kymera Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kymera Therapeutics Inc share’s latest price of $59.81 as on October 18, 2025 at 1:29 am IST, you will get 0.1672 shares of Kymera Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Kymera Therapeutics Inc has given to Indian investors in the last 5 years?
Kymera Therapeutics Inc stock has given 55.89% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?